Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy

Heart disease is the leading cause of death in patients with diabetes.[1][1] Although advances in medical management and lifestyle interventions have reduced cardiovascular mortality in diabetic patients by as much as 40% over the last decade, the actual number of deaths is predicted to rise as a

• Publication year

  2013

• Venue

  Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease

• Publication date

  2013-11-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/JAHA.113.000433PMID 24275630PMCID 3886738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway

  2013cited by this paper
• An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.

  2013cited by this paper
• The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins.

  2013cited by this paper
• Mitochondria as a therapeutic target in heart failure.

  2013cited by this paper
• A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

  2013cited by this paper
• Fasting plasma triglycerides predict the glycaemic response to treatment of Type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm

  2013cited by this paper
• Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2

  2012cited by this paper
• The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review

  2012cited by this paper
• Caffeine‐stimulated fatty acid oxidation is blunted in CD36 null mice

  2012cited by this paper
• Fenretinide Prevents Lipid-induced Insulin Resistance by Blocking Ceramide Biosynthesis*

  2012cited by this paper
• Chronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response*

  2011cited by this paper
• Implications for Treatment

  2011cited by this paper
• Endoplasmic Reticulum Stress and Diabetic Cardiomyopathy

  2011cited by this paper
• Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation.

  2011cited by this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cited by this paper
• Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies

  2010cited by this paper
• Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide[S]

  2010cited by this paper
• Mitochondrial Dysfunction and Oxidative Damage to Sarcomeric Proteins

  2010cited by this paper
• Restoration of cardiomyocyte function in streptozotocin-induced diabetic rats after treatment with vanadate in a tea decoction.

  2010cited by this paper
• Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.

  2010cited by this paper
• Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.

  2009cited by this paper
• DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity*

  2009influential reference
• Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

  2009influential reference
• Rodent models of diabetic cardiomyopathy

  2009cited by this paper
• Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways Published, JLR Papers in Press, November 24, 2008.

  2009cited by this paper
• Uncoupling proteins: A complex journey to function discovery

  2009cited by this paper
• GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

  2009cited by this paper
• PET detection of the impact of dobutamine on myocardial glucose metabolism in women with type 1 diabetes mellitus

  2008cited by this paper
• Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice.

  2008cited by this paper
• Structure and physiological functions of the human peroxisome proliferator-activated receptor γ

  2008cited by this paper
• The PPAR trio: regulators of myocardial energy metabolism in health and disease.

  2008cited by this paper
• Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy

  2008cited by this paper
• Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options.

  2008cited by this paper
• Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies

  2008cited by this paper
• Lipid accumulation in non-adipose tissue and lipotoxicity.

  2008cited by this paper
• Dysregulated pyruvate dehydrogenase complex in Zucker diabetic fatty rats.

  2008cited by this paper
• Carvedilol in hypertension treatment

  2008influential reference
• Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

  2008cited by this paper
• Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology.

  2008cited by this paper
• The metabolic syndrome.

  2008cited by this paper
• A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study.

  2007cited by this paper
• Safety issues and prospects for future generations of PPAR modulators.

  2007cited by this paper
• Ranolazine in patients with coronary artery disease

  2007cited by this paper
• Insulin efficiently stores triglycerides in adipocytes by inhibiting lipolysis and repressing PGC-1alpha induction.

  2007cited by this paper
• Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study

  2007cited by this paper
• Diabetic cardiomyopathy revisited.

  2007cited by this paper
• Peroxisome Proliferator-Activated Receptor-Alpha Deficiency Protects Aged Mice from Insulin Resistance Induced by High-Fat Diet

  2007cited by this paper
• CD36 Expression Contributes to Age-Induced Cardiomyopathy in Mice

  2007cited by this paper
• CD36 Deficiency Rescues Lipotoxic Cardiomyopathy

  2007cited by this paper
• AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36.

  2007cited by this paper
• High-fat/low-carbohydrate diet reduces insulin-stimulated carbohydrate oxidation but stimulates nonoxidative glucose disposal in humans: An important role for skeletal muscle pyruvate dehydrogenase kinase 4.

  2007cited by this paper
• Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.

  2007cited by this paper
• Perhexiline.

  2007cited by this paper
• Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK.

  2007cited by this paper
• Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle.

  2007cited by this paper
• Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine

  2006cited by this paper
• Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes.

  2006cited by this paper
• Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy.

  2006cited by this paper
• Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus.

  2006cited by this paper
• Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart Failure

  2006cited by this paper
• Disorders of carnitine transport and the carnitine cycle

  2006cited by this paper
• Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice.

  2006cited by this paper
• The biology of incretin hormones.

  2006cited by this paper
• Fatty Acids Attenuate Insulin Regulation of 5′-AMP–Activated Protein Kinase and Insulin Cardioprotection After Ischemia

  2006cited by this paper
• The role of hyperglycemia in FAT/CD36 expression and function

  2006cited by this paper
• Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.

  2006cited by this paper
• Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates

  2006cited by this paper
• Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

  2006cited by this paper
• Absence of Malonyl Coenzyme A Decarboxylase in Mice Increases Cardiac Glucose Oxidation and Protects the Heart From Ischemic Injury

  2006cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.

  2005cited by this paper
• Free Fatty Acids Repress the GLUT4 Gene Expression in Cardiac Muscle via Novel Response Elements*

  2005cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• Mechanisms and models in heart failure: the biomechanical model and beyond.

  2005cited by this paper
• Metabolic syndrome: a clinical and molecular perspective.

  2005cited by this paper
• P/O ratios of mitochondrial oxidative phosphorylation.

  2005cited by this paper
• Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels.

  2005cited by this paper
• Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

  2005cited by this paper
• Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy

  2005cited by this paper
• Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

  2005cited by this paper
• GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats.

  2005cited by this paper
• Metabolic Modulators for Chronic Cardiac Ischemia

  2005cited by this paper
• Trimetazidine induces parkinsonism, gait disorders and tremor.

  2005cited by this paper
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

  2005cited by this paper
• Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

  2005cited by this paper
• Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.

  2004cited by this paper
• Lipids and lipoproteins in patients with type 2 diabetes.

  2004cited by this paper
• Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir

  2004cited by this paper
• Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart

  2004cited by this paper
• The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.

  2004cited by this paper
• Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

  2004cited by this paper
• Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation

  2004cited by this paper
• Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats.

  2004cited by this paper
• Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women

  2004cited by this paper
• Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.

  2004cited by this paper
• Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats.

  2004cited by this paper
• Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.

  2004cited by this paper
• PKC-theta knockout mice are protected from fat-induced insulin resistance.

  2004cited by this paper
• Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

  2004cited by this paper
• Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.

  2004cited by this paper

• A Molecular Perspective on the Intricate Interplay Among Exosomes, Bioenergetic Metabolism, and the Pathogenesis of Diabetic Cardiomyopathy

  2025cites this paper
• ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism.

  2025cites this paper
• Can electrocardiographic repolarization predict diabetes incidence: the Atherosclerosis Risk in Communities Study.

  2025cites this paper
• Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice

  2025cites this paper
• Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction?

  2025cites this paper
• The heart of diabetes: unraveling metabolic drivers of cardiomyopathy

  2025cites this paper
• Cardiac Energy Metabolism in Diabetes: Emerging Therapeutic Targets and Clinical Implications.

  2025cites this paper
• Mechanistic exploration of hexokinase 2 and metabolism in diabetic cardiomyopathy

  2025cites this paper
• Trimetazidine restores autophagy via lncRNA H19/AMPK in diabetic heart: Implications for its therapeutic value against diabetic cardiomyopathy

  2024cites this paper
• Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes

  2024cites this paper
• The double burden: type 1 diabetes and heart failure—a comprehensive review

  2024cites this paper
• Triglyceride glucose index: a significant prognostic marker of heart failure in patients with chronic kidney disease

  2024cites this paper
• Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology

  2024cites this paper
• Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy

  2024cites this paper
• USP7 Promotes Cardiometabolic Disorders and Mitochondrial Homeostasis Dysfunction in Diabetic Mice via stabilizing PGC1β.

  2024cites this paper
• Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases

  2024cites this paper
• Beta-adrenergic agonism protects mitochondrial metabolism in the pancreatectomised rat heart

  2024cites this paper
• Diabetic Cardiomyopathy: What Clinicians Should Know.

  2024cites this paper
• The Effects of Resveratrol Supplementation on the Metabolism of Lipids in Metabolic Disorders.

  2023cites this paper
• Current status and emerging trends of cardiac metabolism from the past 20 years: A bibliometric study

  2023cites this paper
• FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy

  2023influential citation
• Glycometabolism reprogramming: Implications for cardiovascular diseases.

  2023cites this paper
• LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway

  2023cites this paper
• SIRT6: A potential therapeutic target for diabetic cardiomyopathy

  2023cites this paper
• Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

  2023cites this paper
• The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice

  2023cites this paper
• New tool for diseases mechanism studies: Endoplasmic reticulum-targeted fluorescent probes

  2023cites this paper
• Perilipin 5 deficiency aggravates cardiac hypertrophy by stimulating lactate production in leptin-deficient mice

  2023cites this paper
• Penalized Model‐Based Unsupervised Phenomapping Unravels Distinctive HFrEF Phenotypes With Improved Outcomes Discrimination From Sacubitril/Valsartan Treatment Independent of MAGGIC Score

  2023cites this paper
• Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Diabetic Complications.

  2023cites this paper
• The role of histone deacetylases in cardiac energy metabolism in heart diseases.

  2023cites this paper
• Assessment of subclinical left ventricular systolic dysfunction in patients with type 2 diabetes: Relationship with HbA1c and microvascular complications

  2023cites this paper
• Impact of Prenatal Exposure to Maternal Diabetes and High-Fat Diet on Postnatal Myocardial Ketone Body Metabolism in Rats

  2023cites this paper
• Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications

  2023cites this paper
• Metabolic regulation of (-)-epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid on the glucose uptake, lipid accumulation and insulin signalling in cardiac H9c2 cells.

  2022cites this paper
• Does optimal HbA1c in diabetes differ according to drug treatment? An evaluation of national electronic database in Malta.

  2022cites this paper
• What Role do Mitochondria Have in Diastolic Dysfunction? Implications for Diabetic Cardiomyopathy and Heart Failure With Preserved Ejection Function

  2022cites this paper
• Bioactive Spermidine Nanoparticles for Effective Cardiovascular Recovery and Diabetic Therapy

  2022cites this paper
• Policy-Based Diabetes Detection using Formal Runtime Verification Monitors

  2022cites this paper
• Factors predicting cardiac arrest in acute coronary syndrome patients under 50: a state-wide angiographic and forensic evaluation of outcomes.

  2022cites this paper
• Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association.

  2022cites this paper
• Pemodelan Semula Jantung dalam Kardiomiopati Diabetes: Peranan Inflamasi, Tekanan Oksidatif dan Apoptosis yang Mendasari Pembentukan dan Perkembangannya

  2022cites this paper
• SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ

  2021cites this paper
• Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats

  2021cites this paper
• Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications

  2021cites this paper
• Sex Differences of the Diabetic Heart

  2021cites this paper
• Cola nitida infusion modulates cardiometabolic activities linked to cardiomyopathy in diabetic rats.

  2021cites this paper
• SGLT2 Inhibition on Cardiac Mitochondrial Function: Searching for a Sweet Spot

  2021cites this paper
• The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms

  2021cites this paper
• Diabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors

  2021cites this paper
• Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism

  2021cites this paper
• Melatonin as a prospective metabolic regulator in pathologically altered cardiac energy homeostasis

  2021cites this paper
• Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

  2021cites this paper
• Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus

  2021cites this paper
• Estrogen Impairs Adipose Tissue Expansion and Cardiometabolic Profile in Obese-Diabetic Female Rats

  2021cites this paper
• Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1α-PPARα pathway.

  2021cites this paper
• SGLT 2 Inhibitors: Review of Systemic Effects and Safety

  2020cites this paper
• FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes

  2020cites this paper
• Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease

  2020cites this paper
• Yacon (Smallanthus sonchifolius) use as an antioxidant in diabetes

  2020cites this paper
• Deficiency of bone morphogenetic protein-3b induces metabolic syndrome and increases adipogenesis.

  2020cites this paper
• Endothelial Dysfunction: A Contributor to Adverse Cardiovascular Remodeling and Heart Failure Development in Type 2 Diabetes beyond Accelerated Atherogenesis

  2020cites this paper
• Calcium inhibitor inhibits high glucose-induced hypertrophy of H9C2 cells

  2020cites this paper
• KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.

  2020cites this paper
• Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization

  2020cites this paper
• Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier

  2020cites this paper
• Lipid profiling of human diabetic myocardium reveals differences in triglyceride fatty acyl chain length and degree of saturation.

  2020cites this paper
• Calcium and s100a1 protein balance in the brain–heart axis in diabetic male Wistar rats

  2020cites this paper
• Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines.

  2020cites this paper
• Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.

  2020cites this paper
• Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events

  2019cites this paper
• A polyphenol-metal nanoparticle platform for tunable release of liraglutide to improve blood glycemic control and reduce cardiovascular complications in a mouse model of type II diabetes.

  2019cites this paper
• Let's face the fats: palmitate restores cellular redox state in the diabetic heart

  2019cites this paper
• Novel Concepts in Cardiac Energy Metabolism: From Biology to Disease

  2019cites this paper
• Myocardial Energy Stress, Autophagy Induction, and Cardiomyocyte Functional Responses

  2019cites this paper
• Recurrent angina in a diabetic patient

  2019cites this paper
• GROUNDBREAKING ADVANCES IN CARDIOVASCULAR RESEARCH

  2019cites this paper
• Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction

  2019cites this paper
• Mechanisms of protective effects of SGLT2 inhibitors in cardiovascular disease and renal dysfunction.

  2019cites this paper
• Cardiac overexpression of perilipin 2 induces atrial steatosis, connexin 43 remodeling, and atrial fibrillation in aged mice.

  2019cites this paper
• Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts

  2019cites this paper
• Nuclear miR-320 Controls Lipotoxicity.

  2019cites this paper
• Clinical potential relevance of metabolic properties of SGLT2 inhibitors in patients with heart failure

  2018cites this paper
• Long non-coding RNAs in diabetes and diabetic cardiomyopathy

  2018cites this paper
• PPARδ, a Potential Therapeutic Target for Heart Disease

  2018cites this paper
• The heart in lack of oxygen? A revisited method to improve cardiac performance ex vivo.

  2018cites this paper
• Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications

  2018cites this paper
• Spirulina platensis Alleviates the Liver, Brain and Heart Oxidative Stress in Type 1 Diabetic Rats

  2018cites this paper
• LncRNAs: Proverbial Genomic “Junk” or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?

  2018cites this paper
• Tissue Engineering Platforms for Cardiac Pathology in Diabetes: In Vitro and In Vivo Studies

  2018cites this paper
• Cardiac effects of SGLT2 inhibitors: the sodium hypothesis

  2018cites this paper
• Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.

  2018cites this paper
• Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management.

  2018cites this paper
• Molecular mechanism of doxorubicin‐induced cardiomyopathy – An update

  2018cites this paper
• An “Exercise” in Cardiac Metabolism

  2018cites this paper
• Metabolic remodelling in heart failure

  2018cites this paper
• Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials

  2018influential citation
• Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy.

  2018cites this paper
• Recovery of Cardiac Remodeling and Dysmetabolism by Pancreatic Islet Injury Improvement in Diabetic Rats after Yacon Leaf Extract Treatment

  2018cites this paper
• Metabolic Effects of Metformin in the Failing Heart

  2018cites this paper